Latham & Watkins Adds Experienced Healthcare and Life Sciences Partner in Frankfurt
Latham & Watkins is pleased to announce that Deniz Tschammler will join the firm’s Frankfurt office as a partner in the Corporate Department and a member of the Healthcare & Life Sciences Practice. Tschammler advises pharmaceutical and medical technology companies, investors, and digital health providers on a variety of complex regulatory, transactional, and sector-specific compliance matters.
“We are excited to welcome Deniz to the firm," said Burc Hesse, Managing Partner of Latham & Watkins in Germany. “This is a great step forward in our growth strategy for the region, within a key industry that offers numerous opportunities for expansion and innovation. Deniz’s extensive knowledge and experience in advising leading healthcare and life sciences companies and investors will significantly enhance our existing capabilities in Germany and throughout Europe.”
Tschammler regularly counsels domestic and international clients on the regulatory implications of transactions and collaborations, market entry and access, digitization strategies, and disputes with competitors and authorities. He also advises on industry-specific compliance and governance matters.
“Deniz brings a wealth of invaluable experience in advising on high-stakes regulatory and transactional matters that are central to our global practice,” adds Eveline Van Keymeulen, Global Vice Chair of Latham’s Healthcare & Life Sciences Practice & Industry Group. “Healthcare and life sciences is a vibrant and rapidly evolving industry worldwide and a key pillar of the firm’s global strategy. Deniz’s arrival highlights the critical importance we place on this sector for our growth strategy and expansion opportunities in Europe and beyond.”
”Deniz is a highly regarded lawyer, with superb knowledge and understanding of Europe’s dynamic regulatory landscape,” said Tobias Larisch, Regional Corporate Department Chair Continental Europe of Latham & Watkins. “Deniz’s addition to our European practice further reinforces our commitment to providing the best expertise for our clients’ most complex matters, both throughout the region and globally.”
Tschammler will join Latham & Watkins from McDermott Will & Emery. He completed his undergraduate degree in Law at the University of Frankfurt, before receiving a PhD in pharmaceutical law from the University of Marburg and an LLM from Kings College, London. He earned an Executive MBA from the University of St Gallen.
About Latham & Watkins
Latham & Watkins delivers innovative solutions to complex legal and business challenges around the world. From a global platform, our lawyers advise clients on market-shaping transactions, high-stakes litigation and trials, and sophisticated regulatory matters. Latham is one of the world’s largest providers of pro bono services, steadfastly supports initiatives designed to advance diversity within the firm and the legal profession, and is committed to exploring and promoting environmental sustainability.
Notes to Editors
1 Latham & Watkins operates worldwide as a limited liability partnership organized under the laws of the State of Delaware (USA) with affiliated limited liability partnerships conducting the practice in France, Hong Kong, Italy, Singapore, and the United Kingdom and as an affiliated partnership conducting the practice in Japan. Latham & Watkins operates in Israel through a limited liability company, in South Korea as a Foreign Legal Consultant Office, and in Saudi Arabia through a limited liability company.